The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

P. Bettembuk; H. P. Bhattoa; A. Balogh; G. Szegedi; E. Kiss

doi:10.1007/s00198-003-1553-6

The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

Osteoporosis International ◽

10.1007/s00198-003-1553-6 ◽

2004 ◽

Vol 15 (5) ◽

pp. 396-404 ◽

Cited By ~ 17

Author(s):

P. Bettembuk ◽

H. P. Bhattoa ◽

A. Balogh ◽

G. Szegedi ◽

E. Kiss

Keyword(s):

Lupus Erythematosus ◽

Biochemical Markers ◽

Estrogen Replacement Therapy ◽

Controlled Trial ◽

Estrogen Replacement ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Markers Of Bone Turnover ◽

Transdermal Estrogen

Download Full-text

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

Osteoporosis International ◽

10.1007/s00198-005-0037-2 ◽

2006 ◽

Vol 17 (5) ◽

pp. 716-723 ◽

Cited By ~ 48

Author(s):

W. F. Lems ◽

M. C. Lodder ◽

P. Lips ◽

J. W. J. Bijlsma ◽

P. Geusens ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Chronic Treatment ◽

Low Dose ◽

Controlled Trial ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Markers Of Bone Turnover ◽

Positive Effect ◽

Dose Prednisone

Download Full-text

Alveolar and Postcranial Bone Density in Postmenopausal Women Receiving Hormone/Estrogen Replacement Therapy: A Randomized, Double-blind, Placebo-Controlled Trial—Correction

Archives of Internal Medicine ◽

10.1001/archinte.164.1.96 ◽

2004 ◽

Vol 164 (1) ◽

pp. 96

Keyword(s):

Bone Density ◽

Replacement Therapy ◽

Postmenopausal Women ◽

Estrogen Replacement Therapy ◽

Controlled Trial ◽

Estrogen Replacement ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Early Changes in Biochemical Markers of Bone Turnover Are Associated with Long-Term Changes in Bone Mineral Density in Elderly Women on Alendronate, Hormone Replacement Therapy, or Combination Therapy: A Three-Year, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2004-1091 ◽

2005 ◽

Vol 90 (5) ◽

pp. 2762-2767 ◽

Cited By ~ 62

Author(s):

Susan L. Greenspan ◽

Neil M. Resnick ◽

Robert A. Parker

Keyword(s):

Bone Mineral Density ◽

Biochemical Markers ◽

Elderly Women ◽

Hormone Replacement ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Markers Of Bone Turnover ◽

Long Term Changes

Download Full-text

Vitamin D Supplementation Associated With 12-Weeks Multimodal Training in Low Bone Mineral Density Older Women: A Randomized Double-Blind Placebo-Controlled Trial

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2020.09.153 ◽

2020 ◽

Vol 101 (11) ◽

pp. e51-e52

Author(s):

Guilherme Brech ◽

Adriana Machado-Lima ◽

Marta Ferreira Bastos ◽

Julia Maria D’Andréa Greve ◽

Angelica Alonso

Keyword(s):

Bone Mineral Density ◽

Vitamin D ◽

Older Women ◽

Bone Mineral ◽

Controlled Trial ◽

Vitamin D Supplementation ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Multimodal Training

Download Full-text

A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus.

Annals of the Rheumatic Diseases ◽

10.1136/ard.47.6.496 ◽

1988 ◽

Vol 47 (6) ◽

pp. 496-502 ◽

Cited By ~ 25

Author(s):

C G Mackworth-Young ◽

J David ◽

S H Morgan ◽

G R Hughes

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Controlled Trial ◽

Systemic Lupus ◽

Intravenous Methylprednisolone ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomised double blind placebo controlled trial assessing the effect of once weekly risedronate on bone mineral density in adults with cystic fibrosis

http://isrctn.org/> ◽

10.1186/isrctn36453336 ◽

2013 ◽

Author(s):

Charles Haworth

Keyword(s):

Bone Mineral Density ◽

Cystic Fibrosis ◽

Bone Mineral ◽

Controlled Trial ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus

Rheumatology International ◽

10.1007/s00296-001-0149-8 ◽

2001 ◽

Vol 21 (3) ◽

pp. 97-102 ◽

Cited By ~ 18

Author(s):

Harjit Bhattoa ◽

Emese Kiss ◽

Peter Bettembuk ◽

Adam Balogh

Keyword(s):

Bone Mineral Density ◽

Systemic Lupus Erythematosus ◽

Bone Turnover ◽

Bone Mineral ◽

Lupus Erythematosus ◽

Biochemical Markers ◽

Hormonal Status ◽

Mineral Density ◽

Systemic Lupus ◽

Markers Of Bone Turnover

Download Full-text

Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

Rheumatology and Therapy ◽

10.1007/s40744-021-00351-7 ◽

2021 ◽

Author(s):

Anca D. Askanase ◽

Dale Wright ◽

Enxu Zhao ◽

Julie Zhu ◽

Roman Bilyk ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Controlled Trial ◽

Active Systemic Lupus Erythematosus ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc

Download Full-text

Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2018-213032 ◽

2018 ◽

Vol 77 (6) ◽

pp. 883-889 ◽

Cited By ~ 33

Author(s):

Joan T Merrill ◽

William R Shanahan ◽

Morton Scheinberg ◽

Kenneth C Kalunian ◽

David Wofsy ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Controlled Trial ◽

Selective Inhibitor ◽

Phase Iii ◽

Systemic Lupus ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

B Cell Activating Factor

Download Full-text

Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Rheumatology and Therapy ◽

10.1007/s40744-021-00353-5 ◽

2021 ◽

Author(s):

Anca D. Askanase ◽

Enxu Zhao ◽

Julie Zhu ◽

Roman Bilyk ◽

Richard A. Furie

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Controlled Trial ◽

Active Systemic Lupus Erythematosus ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo

Download Full-text